glp-1 produced by for Weight Loss and Diabetes The Multifaceted Nature of GLP-1:

Such serum inevitably contains a mixture of antibodies which means the antibodies will vary in their specificity

GLP-1 RAs are a class of medications that have traditionally been used to manage diabetes but are now also used to help with weight loss

SCFAs activate receptors on L-cells that regulate GLP-1 secretion

They can improve liver disease, cardiovascular health, sleep apnea and may lower cancer risk

In the heart, validated studies find the receptor concentrated in the sinoatrial node, which explains the modest increase in heart rate, and in atrial myocytes, where it stimulates the release of atrial natriuretic peptide

However, newer GLP-1 medications, such as tirzepatide, which target both GLP-1 and GIP receptors, may be even more effective for weight loss